A Phase Iib Clinical Trial to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine (Nm283) in ... Grant uri icon

date/time interval

  • November 1, 2005 - October 28, 2008

total award amount

  • 19342.49

direct costs

  • 15473.99

sponsor award ID

  • Idenix Pharmaceutica

local award ID

  • 00058695